Despite the protests of the multi-billion dollar pharmaceutical company Pfizer, the FDA have voted to keep the black box warnings on the smoking cessation drug Chantix, known as Champix in Europe.
Only one person of the 11 panel members made up of the Psychopharmacologic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee voted to remove the black box warning.
Despite the evidence showing an increase in suicide, aggression and other bizarre side effects Pfizer's Christopher Wohlberg, MD, PhD, said "We think the available evidence is inconsistent with a boxed warning."
The panel disagreed and warnings will remain in place.
Below is a video presented to the committee meeting by patient advocate Kim Witczak.
These are actual patient testimonies - something Pfizer should pay heed to.